HearHill

HearHill is a leading medical device company in China's cardiovascular disease field, focusing on developing innovative medical devices that improve human health and enhance quality of life. The company is particularly committed to the independent research and development of medical devices and is the first in China to adopt industrial robot automation for the production of heart valves. Through intelligent and high-precision manufacturing methods, HearHill has improved the stability of product quality while reducing costs. The breakthrough in HearHill’s polymer heart valve technology has helped China achieve leapfrog progress in the field of structural heart disease. HearHill is actively advancing international cutting-edge technologies in the cardiac disease field, continuing to strengthen its core technological innovations and accumulation, and aims to establish multiple comprehensive technology platforms. Several of its cardiovascular products have entered or are about to enter stages such as type inspection and clinical trials according to schedule, with expectations for commercial application in the coming years.